Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil domain containing 47 (CCDC47) is a membrane protein localized to the endoplasmic reticulum (ER). It is a component of the multi-pass translocon complex, aiding in the insertion and folding of multi-pass transmembrane proteins into the ER membrane. CCDC47 acts as a chaperone and regulates calcium ion homeostasis within the ER. It is involved in the ER-associated degradation (ERAD) pathway and is necessary for maintaining the organization of the ER during embryogenesis. Its dysfunction has been linked with rare genetic syndromes such as trichohepatoneurodevelopmental syndrome and certain tumors. While CCDC47 is essential for cellular homeostasis and protein quality control, there are currently no marketed drugs targeting it directly, nor is it widely recognized as a therapeutic target in drug development.
Not applicable—no drugs target this protein, so mechanism of drug action is not established
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain containing 47 (CCDC47).